AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
    9.
    发明授权
    AAV-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells 有权
    AAV介导的视网膜神经节细胞中异源视紫红质的亚细胞靶向

    公开(公告)号:US09453241B2

    公开(公告)日:2016-09-27

    申请号:US13696252

    申请日:2011-05-04

    申请人: Zhuo-Hua Pan

    发明人: Zhuo-Hua Pan

    摘要: Microbial type rhodopsins, such as the light-gated cation-selective membrane channel, channel-rhodopsin-2 (Chop2/ChR2) or the ion pump halorhodopsin (HaloR) are expressed in retinal ganglion cells upon transduction using recombinant AAV vectors. Selective targeting of these transgenes for expression in discrete subcellular regions or sites is achieved by including a sorting motif in the vector that can target either the central area or surround (off-center) area of these cells. Nucleic acid molecules comprising nucleotide sequences encoding such rhodopsins and sorting motifs and their use in methods of differential expression of the transgene are disclosed. These compositions and methods provide significant improvements for restoring visual perception and various aspects of vision, particular in patients with retinal disease.

    摘要翻译: 在重组AAV载体转导后,在视网膜神经节细胞中表达微生物型视紫质,例如光门控阳离子选择性膜通道,通道 - 视紫红质-2(Chop2 / ChR2)或离子泵卤素视紫红质(HaloR)。 通过在可以靶向这些细胞的中心区域或环绕(偏心)区域的载体中包含排序基序来实现用于在离散亚细胞区域或位点中表达的这些转基因的选择性靶向。 公开了包含编码这种视紫红质和排序基序的核苷酸序列的核酸分子及其在转基因的差异表达方法中的用途。 这些组合物和方法为恢复视觉感知和视力各方面提供了显着的改进,特别是视网膜疾病患者。